MedPath

Intravenous dexmedetomidine and paracetamol in bupivacaine spinal anesthesia

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2019/04/018801
Lead Sponsor
Department of Anaesthesia and Intensive Care
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. American Society of Anesthesiologists (ASA) class I or II

2. Age: 18 to 70 years

3. Measuring 150-180 cm height, with body mass index (BMI) of 18-35 kg/m2

4. Patients undergoing elective lower abdominal and pelvic surgeries requiring spinal anaesthesia (maximum surgery duration-2hours)

Exclusion Criteria

1. All contraindications to spinal analgesia including bleeding diathesis, infection at the puncture site, spinal deformity, patient on anticoagulants, pre-existing neurological deficits in lower extremities, unwillingness to give consent.

2. Sensory blockade inadequate for surgery.

3. Patients on alpha-2 adrenergic receptors antagonists, calcium channel blockers, or angiotensin-converting enzyme inhibitors.

4. Patients having cardiac rhythm abnormalities.

5. History of alcoholism, drug abuse, and psychiatric disorders.

6. History of allergy to any of the study drugs.

7. Hepatic disease, renal disease, cardiopulmonary disease, hypertension,

diabetes, central or peripheral nervous system disorders.

8. Laparotomy, chronic abdominal pain undergoing treatment with opioid analgesic.

9. Pregnant patients.

10. Orthopaedic surgeries.

11. Surgeries extending more than 2 hours.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath